Easy to create and hard to detect, ground loops can only be prevented through proactive design and strict NEC compliance.

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...

Growatt showcased its latest solar and energy storage innovations at SNEC PV Power Expo 2025 in Shanghai, from June 11–13.